Fulgent Genetics, Inc. (FLGT)

Last Closing Price: 20.72 (2025-05-30)

Net Income (Annual)

Net Income: Company's net profit or loss after all revenues, income items, and expenses have been accounted for. Because this figure is given after preferred dividend expense, it is the net income value allotted to common shareholders.

Fulgent Genetics, Inc. (FLGT) had Net Income of $-42.71M for the most recently reported fiscal year, ending 2024-12-31.

Figures for fiscal year ending 2024-12-31
Income Statement Financials
$283.47M
Net Income
$-42.71M
$176.25M
$107.22M
$357.39M
$-73.92M
$21.96M
$-51.96M
$-41.88M
$-43.82M
$-43.82M
$-43.82M
$-32.17M
$-73.92M
$-54.54M
30.23M
30.23M
$-1.41
$-1.41
Balance Sheet Financials
$353.57M
$105.55M
$866.39M
$1.22B
$72.90M
--
$17.91M
$90.81M
$1.13B
$972.13M
$1.13B
30.84M
Cash Flow Statement Financials
$21.06M
$-58.35M
$-4.85M
$97.47M
$55.28M
$-42.19M
$44.48M
--
--
Fundamental Metrics & Ratios
4.85
--
--
--
0.00
37.82%
-26.08%
-26.08%
-19.24%
-18.33%
-15.07%
$-18.94M
--
--
--
0.23
--
4.11
88.87
-3.88%
-4.51%
-3.59%
-3.88%
$36.61
$-0.63
$0.70